Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor Phase 3 in Hyperphosphatemia (ESRD-HD)
NCT02675998Phase 3Completed
- Sponsor
- Ardelyx
- Start
- Jan 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in hyperphosphatemia, sponsored by Ardelyx. Started Jan 2016; status: completed.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT02675998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675998.